MedTrace Logo

Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy

NCT01302470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-02-19

No results posted yet for this study

Summary

The primary goal of this study is to evaluate the use of robotically -assisted device leads as a primary strategy for heart resynchronization.This trials aims to compare transvenous lead placement with robotic lead placement for cardiac resynchronization therapy.

Conditions

Interventions

PROCEDURE

Primary epicardial placement of left ventricular lead

Epicardial leads will be placed on the left ventricle in the area of the most dyssynchrony . the leads will be attached to a Medtronic Cardiac resynchronization/ AICD/ device

PROCEDURE

Transvenous placement of left ventricular lead

Conventional placement of left ventricular leads performed in the electrophysiology department.

Sponsors & Collaborators

  • Montefiore Medical Center

    collaborator OTHER

  • St. Luke's-Roosevelt Hospital Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01302470 on ClinicalTrials.gov